Brief: Evaxion Announces Business Update And First Quarter 2023 Financial Results
May 31 (Reuters) - Evaxion Biotech A/S EVAX.O :
* EVAXION ANNOUNCES BUSINESS UPDATE AND FIRST QUARTER 2023
FINANCIAL RESULTS
* EVAXION BIOTECH A/S - *CASH AND CASH EQUIVALENTS OF $10.2
MILLION AT MARCH 2023 SUFFICIENT TO FUND OPERATIONS INTO EARLY
DECEMBER 2023
* EVAXION BIOTECH A/S - QTRLY NET LOSS PER SHARE $0.24
Source text for Eikon: ID:nGNXsQ1S0
Further company coverage: EVAX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Evaxion A/S
See all newsEvaxion A/S reports results for the quarter ended June 30 - Earnings Summary
Denmark's Evaxion Q2 net loss narrows on lower expenses
Brief: Evaxion Q2 Basic EPS USD -0.01
Evaxion A/S expected to post a loss of 31 cents a share - Earnings Preview
Brief: Evaxion A/S - Expands Pipeline Of Cancer Vaccine Programs With Evx-05 Against Brain Cancer Glioblastoma